Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban versus dual antiplatelet therapy for acute ischemic cerebrovascular disease
ChiCTR-TRC-13003384Phase 4Completed
- Sponsor
- Department of Neurology, General Hospital of Northern Theater Command
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of argatroban, aspirin and clopidogrel in ischemic stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Department of Neurology, General Hospital of Northern Theater Command. Primary endpoint: NIHSS score. Started Jul 2013; status: completed.
02
Drugs
argatrobanaspirinclopidogrel
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on ChiCTR-TRC-13003384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003384.